Bolt Biotherapeutics Ownership 2024 | Who Owns Bolt Biotherapeutics Now?
Institutional Ownership
59.43%
Insider Ownership
3.46%
Retail Ownership
37.11%
Institutional Holders
35.00
Bolt Biotherapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 10.02% | 0.29% | 3,812,773 | 392,773 | 11.48% | 2,859,580 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 9.25% | 0.24% | 3,521,291 | - | - | 2,640,968 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 7.24% | 0.11% | 2,754,437 | - | - | 2,065,828 | Jun 30, 2024 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 4.97% | 1.09% | 1,891,467 | - | - | 1,418,600 | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 3.58% | 0.19% | 1,363,234 | -336,766 | -19.81% | 1,022,425 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 3.07% | 0.93% | 1,166,952 | - | - | 875,214 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.80% | - | 1,067,405 | 29,802 | 2.87% | 800,554 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 2.76% | 0.16% | 1,049,153 | - | - | 786,865 | Jun 30, 2024 |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 1.89% | 0.04% | 719,546 | - | - | 539,659 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.66% | 0.25% | 630,507 | 112,555 | 21.73% | 472,880 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.31% | 0.00% | 500,000 | - | - | 375,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.97% | - | 370,790 | 23,223 | 6.68% | 278,146 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.73% | 0.00% | 276,739 | -240,898 | -46.54% | 207,554 | Jun 30, 2024 |
| BLACKROCK INC. | 0.70% | - | 267,068 | 12,110 | 4.75% | 200,301 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.49% | 0.03% | 185,999 | 180,999 | 3619.98% | 139,499 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.30% | 0.01% | 113,797 | 17,124 | 17.71% | 85,348 | Jun 30, 2024 |
| FMR LLC | 0.23% | - | 86,613 | 7,714 | 9.78% | 64,960 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.22% | 0.00% | 85,200 | -26,000 | -23.38% | 63,900 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.14% | 0.00% | 54,400 | 19,200 | 54.55% | 40,800 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.14% | 0.00% | 53,886 | 30,072 | 126.28% | 40,415 | Jun 30, 2024 |
Bolt Biotherapeutics's largest institutional shareholder is TANG CAPITAL MANAGEMENT LLC, holding 10.02% of the company's total share outstanding, currently valued at $2.86M. The top 10 institutional shareholders own together 47.22% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 4.97% | 1.09% | 1,891,467 | - | - | 1,418,600 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 3.07% | 0.93% | 1,166,952 | - | - | 875,214 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 10.02% | 0.29% | 3,812,773 | 392,773 | 11.48% | 2,859,580 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.66% | 0.25% | 630,507 | 112,555 | 21.73% | 472,880 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 9.25% | 0.24% | 3,521,291 | - | - | 2,640,968 | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 3.58% | 0.19% | 1,363,234 | -336,766 | -19.81% | 1,022,425 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 2.76% | 0.16% | 1,049,153 | - | - | 786,865 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 7.24% | 0.11% | 2,754,437 | - | - | 2,065,828 | Jun 30, 2024 |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 1.89% | 0.04% | 719,546 | - | - | 539,659 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.49% | 0.03% | 185,999 | 180,999 | 3619.98% | 139,499 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.30% | 0.01% | 113,797 | 17,124 | 17.71% | 85,348 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.22% | 0.00% | 85,200 | -26,000 | -23.38% | 63,900 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.31% | 0.00% | 500,000 | - | - | 375,000 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.14% | 0.00% | 53,886 | 30,072 | 126.28% | 40,415 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.73% | 0.00% | 276,739 | -240,898 | -46.54% | 207,554 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.14% | 0.00% | 54,400 | 19,200 | 54.55% | 40,800 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.09% | 0.00% | 34,488 | 34,488 | 100.00% | 25,866 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.04% | - | 15,000 | - | - | 11,250 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.97% | - | 370,790 | 23,223 | 6.68% | 278,146 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.80% | - | 1,067,405 | 29,802 | 2.87% | 800,554 | Jun 30, 2024 |
The largest Bolt Biotherapeutics shareholder by % of total assets is PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC. The company owns 1.89M shares of Bolt Biotherapeutics (BOLT), representing 1.09% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 10.02% | 0.29% | 3,812,773 | 392,773 | 11.48% | 2,859,580 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.49% | 0.03% | 185,999 | 180,999 | 3619.98% | 139,499 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.66% | 0.25% | 630,507 | 112,555 | 21.73% | 472,880 | Jun 30, 2024 |
| UBS GROUP AG | 0.13% | - | 48,825 | 36,654 | 301.16% | 36,619 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.09% | 0.00% | 34,488 | 34,488 | 100.00% | 25,866 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.14% | 0.00% | 53,886 | 30,072 | 126.28% | 40,415 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.80% | - | 1,067,405 | 29,802 | 2.87% | 800,554 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.97% | - | 370,790 | 23,223 | 6.68% | 278,146 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.14% | 0.00% | 54,400 | 19,200 | 54.55% | 40,800 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.30% | 0.01% | 113,797 | 17,124 | 17.71% | 85,348 | Jun 30, 2024 |
| BLACKROCK INC. | 0.70% | - | 267,068 | 12,110 | 4.75% | 200,301 | Jun 30, 2024 |
| MORGAN STANLEY | 0.09% | - | 33,687 | 9,000 | 36.46% | 25,266 | Jun 30, 2024 |
| FMR LLC | 0.23% | - | 86,613 | 7,714 | 9.78% | 64,960 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.00% | - | 1,000 | 1,000 | 100.00% | 750 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 2 | - | - | 2 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 628 | - | - | 471 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 840 | - | - | 630 | Jun 30, 2024 |
| SALEM INVESTMENT COUNSELORS INC | 0.00% | - | 40 | - | - | 30 | Jun 30, 2024 |
| STATE STREET CORP | 0.12% | - | 47,437 | - | - | 35,578,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.04% | - | 15,000 | - | - | 11,250 | Jun 30, 2024 |
As of Jun 30 2024, Bolt Biotherapeutics's largest institutional buyer is TANG CAPITAL MANAGEMENT LLC. The company purchased 392.77K stocks of BOLT, valued at $2.86M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -1,541,000 | -100.00% | - | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 3.58% | 0.19% | 1,363,234 | -336,766 | -19.81% | 1,022,425 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.73% | 0.00% | 276,739 | -240,898 | -46.54% | 207,554 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -78,020 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -45,956 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.22% | 0.00% | 85,200 | -26,000 | -23.38% | 63,900 | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -12,826 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -10,938 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 184 | -5,362 | -96.68% | 138 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -211 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.11% | - | 40,895 | -110 | -0.27% | 30,671,000 | Jun 30, 2024 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 4.97% | 1.09% | 1,891,467 | - | - | 1,418,600 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 3.07% | 0.93% | 1,166,952 | - | - | 875,214 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 9.25% | 0.24% | 3,521,291 | - | - | 2,640,968 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 2.76% | 0.16% | 1,049,153 | - | - | 786,865 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 7.24% | 0.11% | 2,754,437 | - | - | 2,065,828 | Jun 30, 2024 |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 1.89% | 0.04% | 719,546 | - | - | 539,659 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.31% | 0.00% | 500,000 | - | - | 375,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.04% | - | 15,000 | - | - | 11,250 | Jun 30, 2024 |
| STATE STREET CORP | 0.12% | - | 47,437 | - | - | 35,578,000 | Jun 30, 2024 |
As of Jun 30 2024, Bolt Biotherapeutics's biggest institutional seller is ORBIMED ADVISORS LLC. The company sold -1.54M shares of BOLT, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ASSENAGON ASSET MANAGEMENT S.A. | 0.09% | 0.00% | 34,488 | 34,488 | 100.00% | 25,866 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.00% | - | 1,000 | 1,000 | 100.00% | 750 | Jun 30, 2024 |
Bolt Biotherapeutics's largest new institutional shareholder by number of shares is ASSENAGON ASSET MANAGEMENT S.A., purchased 34.49K shares, valued at $25.87K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -1,541,000 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -78,020 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -45,956 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -12,826 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -10,938 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -211 | -100.00% | - | Jun 30, 2024 |
Bolt Biotherapeutics's largest sold out institutional shareholder by shares sold is ORBIMED ADVISORS LLC, sold -1.54M shares, valued at -, as of undefined.
Bolt Biotherapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA LIFE SCIENCES INVESTORS | 0.14% | 65,025 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.05% | 1,097 | - | - | Dec 31, 2023 |
| BRIDGEWAY FUNDS INC | 0.05% | 111,200 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.01% | 114,235 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 13,027 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 50,695 | - | - | Aug 31, 2023 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 62,500 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 35,008 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,361 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 21,814 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 112,799 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 50,116 | -579 | -1.14% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,018,671 | -57,842 | -5.37% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 27,696 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 201,205 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 14,925 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 362 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 321,840 | 2,579 | 0.81% | Feb 29, 2024 |
| TARGET PORTFOLIO TRUST | 0.00% | 19,400 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,754 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 18,932 | - | - | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 6,151 | - | - | Mar 31, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,852 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 6,540 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 28,500 | - | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 859,826 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 10,418 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 800 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 6,341 | - | - | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 9,024 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 53,393 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 12,324 | - | - | Mar 28, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 3,417 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 220 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 5,000 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 576 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 218 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 489 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 164,751 | - | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 7,666 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 76,846 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 807 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 121 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 31,644 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 8,483 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 699 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 136 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,988 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 1,398 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,792 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 22 | - | - | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 49,709 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 43,060 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 2,455 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 3,166 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,586 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 9,513 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 4,508 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 10,118 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 600 | - | - | Mar 31, 2023 |
| JPMorgan Trust I | 0.00% | 12,091 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 21,700 | - | - | Mar 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 18,430 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 795 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 153 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,524 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 57,073 | -1,659 | -2.82% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 12,196 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 3,615 | -25 | -0.69% | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 3,600 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 702 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,040 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 8,410 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,693 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,138 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,913 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 27 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,300 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 2,306 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 3,100 | - | - | Feb 29, 2024 |
Bolt Biotherapeutics's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 65.03K shares, compromising 0.14% of its total assets.
Bolt Biotherapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 35 | -5.41% |
| 31 Mar, 24 | 37 | -2.63% |
| 31 Dec, 23 | 38 | 15.15% |
| 30 Sep, 23 | 33 | -17.50% |
| 30 Jun, 23 | 40 | - |
| 31 Mar, 23 | 40 | -6.98% |
| 31 Dec, 22 | 43 | -17.31% |
| 30 Sep, 22 | 52 | -8.77% |
| 30 Jun, 22 | 57 | -9.52% |
| 31 Mar, 22 | 63 | 6.78% |
| 31 Dec, 21 | 59 | -19.18% |
| 30 Sep, 21 | 73 | 19.67% |
| 30 Jun, 21 | 61 | -12.86% |
| 31 Mar, 21 | 70 | - |
As of 30 Jun 24, 35 institutions are holding Bolt Biotherapeutics's shares, representing a decrease of -5.41% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 22,625,732 | -5.73% |
| 31 Mar, 24 | 24,001,384 | -0.52% |
| 31 Dec, 23 | 24,125,809 | -1.70% |
| 30 Sep, 23 | 24,542,560 | -2.54% |
| 30 Jun, 23 | 25,183,106 | 7.98% |
| 31 Mar, 23 | 23,321,163 | 13.26% |
| 31 Dec, 22 | 20,591,606 | -23.13% |
| 30 Sep, 22 | 26,788,931 | -0.27% |
| 30 Jun, 22 | 26,860,543 | -7.52% |
| 31 Mar, 22 | 29,044,937 | -13.71% |
| 31 Dec, 21 | 33,659,408 | -5.24% |
| 30 Sep, 21 | 35,522,522 | 6.70% |
| 30 Jun, 21 | 33,292,492 | 5.71% |
| 31 Mar, 21 | 31,494,590 | - |
Bolt Biotherapeutics (BOLT) has 22.63M shares outstanding as of 30 Jun 24, down -5.73% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 59.43% | 1.48% |
| 31 Mar, 24 | 63.48% | 1.56% |
| 31 Dec, 23 | 63.71% | 1.51% |
| 30 Sep, 23 | 65.01% | 1.46% |
| 30 Jun, 23 | 66.83% | 1.74% |
| 31 Mar, 23 | 61.89% | 2.04% |
| 31 Dec, 22 | 55.12% | 1.08% |
| 30 Sep, 22 | 71.52% | 1.38% |
| 30 Jun, 22 | 72.02% | 1.18% |
| 31 Mar, 22 | 78.23% | 0.96% |
| 31 Dec, 21 | 90.47% | 0.99% |
| 30 Sep, 21 | 95.47% | 1.15% |
| 30 Jun, 21 | 90.98% | 0.42% |
| 31 Mar, 21 | 146.50% | - |
As of 30 Jun 24, Bolt Biotherapeutics is held by 59.43% institutional shareholders, representing a 1.48% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | 60.00% |
| 31 Mar, 24 | 10 | -33.33% |
| 31 Dec, 23 | 15 | 50.00% |
| 30 Sep, 23 | 10 | -28.57% |
| 30 Jun, 23 | 14 | -22.22% |
| 31 Mar, 23 | 18 | 5.88% |
| 31 Dec, 22 | 17 | -5.56% |
| 30 Sep, 22 | 18 | -41.94% |
| 30 Jun, 22 | 31 | 10.71% |
| 31 Mar, 22 | 28 | -20.00% |
| 31 Dec, 21 | 35 | -27.08% |
| 30 Sep, 21 | 48 | 45.45% |
| 30 Jun, 21 | 33 | -52.86% |
| 31 Mar, 21 | 70 | - |
16 institutional shareholders have increased their position in BOLT stock as of 30 Jun 24 compared to 10 in the previous quarter (a 60.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | -45.45% |
| 31 Mar, 24 | 11 | -8.33% |
| 31 Dec, 23 | 12 | 50.00% |
| 30 Sep, 23 | 8 | -11.11% |
| 30 Jun, 23 | 9 | 50.00% |
| 31 Mar, 23 | 6 | -45.45% |
| 31 Dec, 22 | 11 | -45.00% |
| 30 Sep, 22 | 20 | 33.33% |
| 30 Jun, 22 | 15 | -31.82% |
| 31 Mar, 22 | 22 | 120.00% |
| 31 Dec, 21 | 10 | -9.09% |
| 30 Sep, 21 | 11 | -31.25% |
| 30 Jun, 21 | 16 | - |
| 31 Mar, 21 | - | - |
6 institutional shareholders have reduced their position in BOLT stock as of 30 Jun 24 compared to 11 in the previous quarter (a -45.45% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 35 | -5.41% | 22,625,732 | -5.73% | 59.43% | 1.48% | 16 | 60.00% | 6 | -45.45% |
| 31 Mar, 24 | 37 | -2.63% | 24,001,384 | -0.52% | 63.48% | 1.56% | 10 | -33.33% | 11 | -8.33% |
| 31 Dec, 23 | 38 | 15.15% | 24,125,809 | -1.70% | 63.71% | 1.51% | 15 | 50.00% | 12 | 50.00% |
| 30 Sep, 23 | 33 | -17.50% | 24,542,560 | -2.54% | 65.01% | 1.46% | 10 | -28.57% | 8 | -11.11% |
| 30 Jun, 23 | 40 | - | 25,183,106 | 7.98% | 66.83% | 1.74% | 14 | -22.22% | 9 | 50.00% |
| 31 Mar, 23 | 40 | -6.98% | 23,321,163 | 13.26% | 61.89% | 2.04% | 18 | 5.88% | 6 | -45.45% |
| 31 Dec, 22 | 43 | -17.31% | 20,591,606 | -23.13% | 55.12% | 1.08% | 17 | -5.56% | 11 | -45.00% |
| 30 Sep, 22 | 52 | -8.77% | 26,788,931 | -0.27% | 71.52% | 1.38% | 18 | -41.94% | 20 | 33.33% |
| 30 Jun, 22 | 57 | -9.52% | 26,860,543 | -7.52% | 72.02% | 1.18% | 31 | 10.71% | 15 | -31.82% |
| 31 Mar, 22 | 63 | 6.78% | 29,044,937 | -13.71% | 78.23% | 0.96% | 28 | -20.00% | 22 | 120.00% |
| 31 Dec, 21 | 59 | -19.18% | 33,659,408 | -5.24% | 90.47% | 0.99% | 35 | -27.08% | 10 | -9.09% |
| 30 Sep, 21 | 73 | 19.67% | 35,522,522 | 6.70% | 95.47% | 1.15% | 48 | 45.45% | 11 | -31.25% |
| 30 Jun, 21 | 61 | -12.86% | 33,292,492 | 5.71% | 90.98% | 0.42% | 33 | -52.86% | 16 | - |
| 31 Mar, 21 | 70 | - | 31,494,590 | - | 146.50% | - | 70 | - | - | - |
Bolt Biotherapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Bolt Biotherapeutics's stock was made by Nemec Sarah on May 15 2024, selling - shares at - per share (valued at -).
Bolt Biotherapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 4 | - | - |
| Q2 2024 | 7 | 8 | 87.50% |
| Q1 2024 | 4 | - | - |
| Q4 2023 | 2 | 24 | 8.33% |
| Q2 2023 | 10 | - | - |
| Q1 2023 | 4 | - | - |
| Q4 2022 | 4 | 1 | 400.00% |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 13 | - | - |
| Q1 2022 | 20 | - | - |
| Q4 2021 | 7 | 4 | 175.00% |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 45 | 52 | 86.54% |
4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Bolt Biotherapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 2 | 24 | 8.33% |
| Q2 2023 | 1 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 3 | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 13 | 6 | 216.67% |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Bolt Biotherapeutics's stocks.
BOLT Ownership FAQ
Who Owns Bolt Biotherapeutics?
Bolt Biotherapeutics is owned by institutional shareholders (59.43%), insiders (3.46%), and public (37.11%). The largest institutional shareholder of Bolt Biotherapeutics is TANG CAPITAL MANAGEMENT LLC (10.02% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.14% of total shares).
Who are the major institutional shareholders of Bolt Biotherapeutics?
Bolt Biotherapeutics's major institutional shareholders are TANG CAPITAL MANAGEMENT LLC, VIVO CAPITAL, LLC, SOFINNOVA INVESTMENTS, INC., PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC, and NEWTYN MANAGEMENT, LLC. The top five shareholders own together 35.05% of the company's share outstanding.
How many Bolt Biotherapeutics shareholders are there?
As of Jun 2024, there are 35 institutional shareholders of Bolt Biotherapeutics.
What percentage of Bolt Biotherapeutics is owned by TANG CAPITAL MANAGEMENT LLC?
TANG CAPITAL MANAGEMENT LLC owns 3.81M shares of Bolt Biotherapeutics, representing 10.02% of the company's total shares outstanding, valued at $2.86M (as of Jun 2024).
What percentage of Bolt Biotherapeutics is owned by VIVO CAPITAL, LLC?
As of Jun 2024, VIVO CAPITAL, LLC holds 3.52M shares of Bolt Biotherapeutics (BOLT), compromising 9.25% of the company, valued at $2.64M.
What percentage of Bolt Biotherapeutics is owned by SOFINNOVA INVESTMENTS, INC?
SOFINNOVA INVESTMENTS, INC is the third largest holder of Bolt Biotherapeutics. The company owns 2.75M of the company's shares outstanding (worth $2.07M).